

GlaxoSmithKline have scored another Victory...
Today the US FDA voted to allow GSK's money-making diabetic drug Avandia to remain on the market. However, not everyone on the FDA review panel agreed.
Today the US FDA voted to allow GSK's money-making diabetic drug Avandia to remain on the market. However, not everyone on the FDA review panel agreed.
In fact, out of the 33 panel members, 12 of them wanted to withdraw it, and 10 wanted it to remain on the market with serious revisions to the label. Other than one other member abstaining, the rest were happy to continue 'business as is'.
Hmm...I bet there was a bit of lobbying going on before the vote was made! Is this drug really necessary? Obviously there are widely different opinions about this. One thing that I can safely say is that it should only be a drug of last resort, when the basics (which usually work) have failed...such as diet and exercise.
Unfortunately, Avandia - like so many drugs - is prescribed as the first line of action by many doctors rather than them spending the time to help educate their patients about lifestyle changes to eliminate the cause of the disease and avoid the drug dependency.
You can find out more by reading this article...
You may also like...

New Year, New Ingredients - Total Balance
January 2021 by, Warren Matthews
As their name suggests, our Total Balance range of supplements is designed to provide total support across all...
Read More
Health Matters Newsletter - December 2020
December 2020 by, Warren Matthews
2020... what a year! Massive disruptions for most of us. I hope that you have managed OK and...
Read More
Total Balance Premium Reformulation
November 2020 by, Warren Matthews
The new formulation of Total Balance Premium means our customers can continue to take advantage of the efficacy, quality...
Read More
Leave a Comment